Meghmani Finechem reports 23% fall in Q4 consolidated net profit

25 Apr 2023 Evaluate

Meghmani Finechem has reported results for fourth quarter (Q4) and year ended March 31, 2023.

Meghmani Finechem has reported fall of 22.49% in its net profit at Rs 76.80 crore for the quarter under review as compared to Rs 99.09 crore for the same quarter in the previous year. However, total income of the company increased by 13.17% at Rs 566.72 crore for Q4FY23 as compared to Rs 500.77 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported fall of 22.57% in its net profit at Rs 76.73 crore for the quarter under review as compared to Rs 99.09 crore for the same quarter in the previous year. However, total income of the company increased by 13.17% at Rs 566.72 crore for Q4FY23 as compared to Rs 500.77 crore for the corresponding quarter previous year.

For the year ended March 31, 2023, the company has reported rise of 39.78% in its net profit at Rs 353.36 crore as compared to Rs 252.79 crore for the previous year. Total income of the company increased by 41.24% at Rs 2,196.38 crore for year under review as compared to Rs 1,555.05 crore for year ended March 31, 2022.

For the year ended March 31, 2023, on the consolidated basis, the company has reported 39.76% rise in its net profit at Rs 353.29 crore as compared to Rs 252.79 crore for the previous year. Total income of the company increased by 41.24% at Rs 2,196.38 crore for year under review as compared to Rs 1,555.05 crore for year ended March 31, 2022.

Epigral Share Price

1468.90 -7.60 (-0.51%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
BASF India 4039.90
Tata Chemicals 773.85
SRF 2886.20
Pidilite Inds. 1474.70
Deepak Nitrite 1565.30
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×